ArriVent BioPharma (AVBP) Free Cash Flow (2023 - 2026)
ArriVent BioPharma (AVBP) free cash flow from Mar 31, 2023 to Mar 31, 2026. The TTM ArriVent BioPharma (AVBP) free cash flow is -$134M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
ArriVent BioPharma (AVBP) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +12.44% |
| 3 Years TTM | +99.72% |
| All Time TTM | +52.85% |
Annual Free Cash Flow change of ArriVent BioPharma (AVBP)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$42M | -73.91% |
| 2025 | -$161M | +128.73% |
| 2024 | -$70M | +25.73% |
| 2023 | -$56M | N/A |